Evidence map›Paper›PMID 40593540›Full record

ArticleNature communications2025

Structural Repetition Detector for multi-scale quantitative mapping of molecular complexes through microscopy.

Afonso Mendes, Bruno M Saraiva, Guillaume Jacquemet, João I Mamede, Christophe Leterrier, Ricardo Henriques

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Afonso MendesOptical Cell Biology group, Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Bruno M SaraivaOptical Cell Biology group, Instituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID http://orcid.org/0000-0002-9151-5477
Guillaume JacquemetTurku Bioimaging, University of Turku and Åbo Akademi University, Turku, Finland.ORCID http://orcid.org/0000-0002-9286-920X
João I MamedeDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-6048-1876
Christophe LeterrierAix Marseille Université, CNRS, INP UMR7051, NeuroCyto, Marseille, France. christophe.leterrier@univ-amu.fr.ORCID http://orcid.org/0000-0002-2957-2032
Ricardo HenriquesOptical Cell Biology group, Instituto Gulbenkian de Ciência, Oeiras, Portugal. r.henriques@itqb.unl.pt.ORCID http://orcid.org/0000-0002-2043-5234

Funding

Functionally Defining HIV-Host Interactions During the Early HIV-1 LifecycleR01AI150998 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BIENIASZ, PAUL D., HOPE, THOMAS · 2020 to 2024
$6.8M
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.R01AI177265 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SUMIT K CHANDA, Sunnie Yoh · 2023 to 2026
$3.4M
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV InfectionR61AI169661 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GAGNON, KEITH THOMAS · 2022 to 2024
$1.8M
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV InfectionR33AI169661 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Keith Thomas Gagnon · 2025 to 2026
$1.5M
Role Of Innate Immunity to NeuroHIV in the cART EraR01MH139377 · NIMH · RUSH UNIVERSITY MEDICAL CENTER · PI Joao I. Mamede · 2025 to 2026
$1.3M
Molecular Pathways of Innate Immunity and Substance Abuse in NeuroHIVR61DA058348 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI INACIO MAMEDE, JOAO FILIPE · 2023 to 2024
$928k
Direct live-cell visualization and quantification of interactions between infectious HIV particles in primary target cells.K22AI140963 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI INACIO MAMEDE, JOAO FILIPE · 2020 to 2021
$270k
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101001332EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101099654European Molecular Biology Organization (EMBO) 2020-IG-4734NIAID NIH HHS K22 AI140963NIAID NIH HHS R01 AI150998NIAID NIH HHS R01 AI177265NIAID NIH HHS R33 AI169661NIAID NIH HHS R61 AI169661NIDA NIH HHS R61 DA058348NIMH NIH HHS R01 MH139377Wellcome TrustWellcome Trust (Wellcome) 313383/Z/24/Z
6 · The paper itself

Abstract

From molecules to organelles, cells exhibit recurring structural motifs across multiple scales. Understanding these structures provides insights into their functional roles. While super-resolution microscopy can visualise such patterns, manual detection in large datasets is challenging and biased. We present the Structural Repetition Detector (SReD), an unsupervised computational framework that identifies repetitive biological structures by exploiting local texture repetition. SReD formulates structure detection as a similarity-matching problem between local image regions. It detects recurring patterns without prior knowledge or constraints on the imaging modality. We demonstrate SReD's capabilities on various fluorescence microscopy images. Quantitative analyses of different datasets highlight SReD's utility: estimating the periodicity of spectrin rings in neurons, detecting Human Immunodeficiency Virus type-1 viral assembly, and evaluating microtubule dynamics modulated by End-binding protein 3. Our open-source plugin for ImageJ or FIJI enables unbiased analysis of repetitive structures across imaging modalities in diverse biological contexts.

Indexed as

Image Processing, Computer-AssistedAnimalsHIV-1HumansMicroscopy, FluorescenceMicrotubulesNeuronsSpectrinSpectrin

Identifiers

PMID40593540
PMCPMC12219329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.